List of Tables
Table 1. Global Short Bowel Syndrome Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Short Bowel Syndrome Drugs Market Value by Sale Channel (2024 VS 2031) & (US$ Million)
Table 3. Global Short Bowel Syndrome Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Short Bowel Syndrome Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Short Bowel Syndrome Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Short Bowel Syndrome Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Short Bowel Syndrome Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Short Bowel Syndrome Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Short Bowel Syndrome Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Short Bowel Syndrome Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Short Bowel Syndrome Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Short Bowel Syndrome Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Short Bowel Syndrome Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Short Bowel Syndrome Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Short Bowel Syndrome Drugs Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Short Bowel Syndrome Drugs Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Short Bowel Syndrome Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Short Bowel Syndrome Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Short Bowel Syndrome Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Short Bowel Syndrome Drugs Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Short Bowel Syndrome Drugs Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Short Bowel Syndrome Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Short Bowel Syndrome Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Short Bowel Syndrome Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Short Bowel Syndrome Drugs Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Short Bowel Syndrome Drugs Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Short Bowel Syndrome Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Short Bowel Syndrome Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Short Bowel Syndrome Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Short Bowel Syndrome Drugs Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Short Bowel Syndrome Drugs Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Short Bowel Syndrome Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Short Bowel Syndrome Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Short Bowel Syndrome Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Short Bowel Syndrome Drugs Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Short Bowel Syndrome Drugs Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Short Bowel Syndrome Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Short Bowel Syndrome Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Short Bowel Syndrome Drugs Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Short Bowel Syndrome Drugs Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Short Bowel Syndrome Drugs Sales (K Pcs) by Type (2020-2025)
Table 51. Global Short Bowel Syndrome Drugs Sales (K Pcs) by Type (2026-2031)
Table 52. Global Short Bowel Syndrome Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Short Bowel Syndrome Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Short Bowel Syndrome Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Short Bowel Syndrome Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Short Bowel Syndrome Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Short Bowel Syndrome Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Short Bowel Syndrome Drugs Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Short Bowel Syndrome Drugs Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Short Bowel Syndrome Drugs Sales (K Pcs) by Sale Channel (2020-2025)
Table 61. Global Short Bowel Syndrome Drugs Sales (K Pcs) by Sale Channel (2026-2031)
Table 62. Global Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2020-2025)
Table 63. Global Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2026-2031)
Table 64. Global Short Bowel Syndrome Drugs Revenue (US$ Million) by Sale Channel (2020-2025)
Table 65. Global Short Bowel Syndrome Drugs Revenue (US$ Million) by Sale Channel (2026-2031)
Table 66. Global Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2020-2025)
Table 67. Global Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2026-2031)
Table 68. Global Short Bowel Syndrome Drugs Price (USD/Pcs) by Sale Channel (2020-2025)
Table 69. Global Short Bowel Syndrome Drugs Price (USD/Pcs) by Sale Channel (2026-2031)
Table 70. Emmaus Medical Company Information
Table 71. Emmaus Medical Description and Business Overview
Table 72. Emmaus Medical Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. Emmaus Medical Short Bowel Syndrome Drugs Product
Table 74. Emmaus Medical Recent Developments/Updates
Table 75. Merck Company Information
Table 76. Merck Description and Business Overview
Table 77. Merck Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Merck Short Bowel Syndrome Drugs Product
Table 79. Merck Recent Developments/Updates
Table 80. Takeda Company Information
Table 81. Takeda Description and Business Overview
Table 82. Takeda Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Takeda Short Bowel Syndrome Drugs Product
Table 84. Takeda Recent Developments/Updates
Table 85. Ardelyx Company Information
Table 86. Ardelyx Description and Business Overview
Table 87. Ardelyx Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Ardelyx Short Bowel Syndrome Drugs Product
Table 89. Ardelyx Recent Developments/Updates
Table 90. Naia Pharmaceuticals Company Information
Table 91. Naia Pharmaceuticals Description and Business Overview
Table 92. Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Naia Pharmaceuticals Short Bowel Syndrome Drugs Product
Table 94. Naia Pharmaceuticals Recent Developments/Updates
Table 95. Nutrinia Company Information
Table 96. Nutrinia Description and Business Overview
Table 97. Nutrinia Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Nutrinia Short Bowel Syndrome Drugs Product
Table 99. Nutrinia Recent Developments/Updates
Table 100. OxThera Company Information
Table 101. OxThera Description and Business Overview
Table 102. OxThera Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. OxThera Short Bowel Syndrome Drugs Product
Table 104. OxThera Recent Developments/Updates
Table 105. GLyPharma Therapeutic Company Information
Table 106. GLyPharma Therapeutic Description and Business Overview
Table 107. GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. GLyPharma Therapeutic Short Bowel Syndrome Drugs Product
Table 109. GLyPharma Therapeutic Recent Developments/Updates
Table 110. Sancilio Pharmaceuticals Company Information
Table 111. Sancilio Pharmaceuticals Description and Business Overview
Table 112. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product
Table 114. Sancilio Pharmaceuticals Recent Developments/Updates
Table 115. Zealand Pharma Company Information
Table 116. Zealand Pharma Description and Business Overview
Table 117. Zealand Pharma Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Zealand Pharma Short Bowel Syndrome Drugs Product
Table 119. Zealand Pharma Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Short Bowel Syndrome Drugs Distributors List
Table 123. Short Bowel Syndrome Drugs Customers List
Table 124. Short Bowel Syndrome Drugs Market Trends
Table 125. Short Bowel Syndrome Drugs Market Drivers
Table 126. Short Bowel Syndrome Drugs Market Challenges
Table 127. Short Bowel Syndrome Drugs Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Short Bowel Syndrome Drugs
Figure 2. Global Short Bowel Syndrome Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Short Bowel Syndrome Drugs Market Share by Type: 2024 & 2031
Figure 4. Oral Short Bowel Syndrome Drugs Product Picture
Figure 5. Tablet Short Bowel Syndrome Drugs Product Picture
Figure 6. Global Short Bowel Syndrome Drugs Market Value by Sale Channel (2020-2031) & (US$ Million)
Figure 7. Global Short Bowel Syndrome Drugs Market Share by Sale Channel: 2024 & 2031
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Online Pharmacies
Figure 11. Global Short Bowel Syndrome Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Short Bowel Syndrome Drugs Market Size (2020-2031) & (US$ Million)
Figure 13. Global Short Bowel Syndrome Drugs Sales (2020-2031) & (K Pcs)
Figure 14. Global Short Bowel Syndrome Drugs Average Price (USD/Pcs) & (2020-2031)
Figure 15. Short Bowel Syndrome Drugs Report Years Considered
Figure 16. Short Bowel Syndrome Drugs Sales Share by Manufacturers in 2024
Figure 17. Global Short Bowel Syndrome Drugs Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Short Bowel Syndrome Drugs Players: Market Share by Revenue in Short Bowel Syndrome Drugs in 2024
Figure 19. Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Short Bowel Syndrome Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Short Bowel Syndrome Drugs Sales Market Share by Country (2020-2031)
Figure 22. North America Short Bowel Syndrome Drugs Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Short Bowel Syndrome Drugs Sales Market Share by Country (2020-2031)
Figure 26. Europe Short Bowel Syndrome Drugs Revenue Market Share by Country (2020-2031)
Figure 27. Germany Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Short Bowel Syndrome Drugs Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Short Bowel Syndrome Drugs Revenue Market Share by Region (2020-2031)
Figure 34. China Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Short Bowel Syndrome Drugs Sales Market Share by Country (2020-2031)
Figure 44. Latin America Short Bowel Syndrome Drugs Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Short Bowel Syndrome Drugs Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Short Bowel Syndrome Drugs Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Short Bowel Syndrome Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Short Bowel Syndrome Drugs by Type (2020-2031)
Figure 54. Global Revenue Market Share of Short Bowel Syndrome Drugs by Type (2020-2031)
Figure 55. Global Short Bowel Syndrome Drugs Price (USD/Pcs) by Type (2020-2031)
Figure 56. Global Sales Market Share of Short Bowel Syndrome Drugs by Sale Channel (2020-2031)
Figure 57. Global Revenue Market Share of Short Bowel Syndrome Drugs by Sale Channel (2020-2031)
Figure 58. Global Short Bowel Syndrome Drugs Price (USD/Pcs) by Sale Channel (2020-2031)
Figure 59. Short Bowel Syndrome Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
